Keizo Kanasaki

Researcher Name Resolver ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Topics

Breast Cancer Cells

Diabetic Nephropathy

Top Venues

Journal of diabetes investigation

Scientific reports

Molecular cancer research : MCR

Redox report : communications in free radical research

This page only lists publications with an associated author ORCID identifier.

Publications

Emi Kawakita, Keizo Kanasaki
Cancer biology in diabetes update: Focusing on antidiabetic drugs. Journal of diabetes investigation (2024)
Atsuhisa Sato, Daloha Rodriguez-Molina, Kanae Yoshikawa-Ryan, Satoshi Yamashita, Suguru Okami, Fangfang Liu, Alfredo Farjat, Nikolaus G Oberprieler, Csaba Pal Kovesdy, Keizo Kanasaki, David Vizcaya
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan-A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform. Journal of clinical medicine 13 (17) (2024)
Emi Kawakita, Keizo Kanasaki
Cancer biology in diabetes update: Focusing on antidiabetic drugs. Journal of diabetes investigation 15 (5) (2024)
Emi Kawakita, Keizo Kanasaki
Cancer biology in diabetes update: Focusing on antidiabetic drugs. Journal of diabetes investigation 15 (5) (2024)
Emi Kawakita, Keizo Kanasaki
Cancer biology in diabetes update: Focusing on antidiabetic drugs. Journal of diabetes investigation 15 (5) (2024)
Emi Kawakita, Keizo Kanasaki
Cancer biology in diabetes update: Focusing on antidiabetic drugs. Journal of diabetes investigation 15 (5) (2024)
Keizo Kanasaki, Kohjiro Ueki, Masaomi Nangaku
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes. Clinical and experimental nephrology (2024)
Hirofumi Makino, Keizo Kanasaki
Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study. Journal of diabetes investigation (2023)
Juthi Adhikari, Taro Hirai, Emi Kawakita, Kunimitsu Iwai, Daisuke Koya, Keizo Kanasaki
Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis. Journal of diabetes investigation (2023)
Emi Kawakita, Fan Yang, Sen Shi, Yuta Takagaki, Daisuke Koya, Keizo Kanasaki
Inhibition of Dipeptidyl Peptidase-4 Activates Autophagy to Promote Survival of Breast Cancer Cells via the mTOR/HIF-1α Pathway. Cancers 15 (18) (2023)
Juthi Adhikari, Taro Hirai, Emi Kawakita, Kunimitsu Iwai, Daisuke Koya, Keizo Kanasaki
Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis. Journal of diabetes investigation (2023)
Kohei Kaku, Yayoi Nakayama, Junko Yabuuchi, Yusuke Naito, Keizo Kanasaki
Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study. Expert opinion on drug safety (2023)
Juthi Adhikari, Taro Hirai, Emi Kawakita, Kunimitsu Iwai, Daisuke Koya, Keizo Kanasaki
Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis. Journal of diabetes investigation (2023)
Ling Zhang, Sibylle Hauske, Yasuhisa Ono, Moe H Kyaw, Dominik Steubl, Yusuke Naito, Keizo Kanasaki
Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study. BMJ open 12 (2) (2022)
Keiji Shimada, Keizo Kanasaki, Makoto Kato, Yoshio Ogura, Yuta Takagaki, Itaru Monno, Taro Hirai, Munehiro Kitada, Daisuke Koya
Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice. Journal of diabetes investigation 13 (6) (2022)
Kai Takedani, Masakazu Notsu, Sayo Koike, Mika Yamauchi, Takayasu Mori, Eisei Sohara, Asuka Yamauchi, Kaori Yoshikane, Takafumi Ito, Keizo Kanasaki
Osteomalacia caused by atypical renal tubular acidosis with vitamin D deficiency: a case report. CEN case reports 10 (2) (2021)
Yuta Takagaki, Keizo Kanasaki
Classical molecule in diabetic kidney hypertrophy is linked to defects in self-eating through fine-tuning. Journal of diabetes investigation 12 (5) (2021)
Swayam Prakash Srivastava, Han Zhou, Ocean Setia, Bing Liu, Keizo Kanasaki, Daisuke Koya, Alan Dardik, Carlos Fernández-Hernando, Julie Elizabeth Goodwin
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nature communications 12 (1) (2021)
Swayam Prakash Srivastava, Julie Elizabeth Goodwin, Keizo Kanasaki, Daisuke Koya
Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease. British journal of pharmacology 177 (16) (2020)
Emi Kawakita, Fan Yang, Asako Kumagai, Yuta Takagaki, Munehiro Kitada, Yasuo Yoshitomi, Takayuki Ikeda, Yuka Nakamura, Yasuhito Ishigaki, Keizo Kanasaki, Daisuke Koya
Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling. Molecular cancer research : MCR 19 (1) (2020)
Swayam Prakash Srivastava, Julie Elizabeth Goodwin, Keizo Kanasaki, Daisuke Koya
Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs. Genes 11 (2) (2020)
Keizo Kanasaki
N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects. Journal of diabetes investigation 11 (3) (2020)
Haijie Liu, Yuta Takagaki, Asako Kumagai, Keizo Kanasaki, Daisuke Koya
The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation. Journal of diabetes investigation 12 (5) (2020)
Yuta Takagaki, Seon Myeong Lee, Zha Dongqing, Munehiro Kitada, Keizo Kanasaki, Daisuke Koya
Endothelial autophagy deficiency induces IL6 - dependent endothelial mesenchymal transition and organ fibrosis. Autophagy 16 (10) (2020)
Yuiko Mizunuma, Keizo Kanasaki, Kyoko Nitta, Yuka Nakamura, Yasuhito Ishigaki, Yuta Takagaki, Munehiro Kitada, Shaolan Li, Haijie Liu, Jinpeng Li, Isao Usui, Yoshimasa Aso, Daisuke Koya
CD-1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis. Journal of diabetes investigation 11 (6) (2020)
Yuta Takagaki, Sen Shi, Makoto Katoh, Munehiro Kitada, Keizo Kanasaki, Daisuke Koya
Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice. Scientific reports 9 (1) (2019)
Munehiro Kitada, Yoshio Ogura, Kyoko Nitta, Mizue Fujii, Keizo Kanasaki, Kazunori Konishi, Yasuo Iida, Atsushi Nakagawa, Daisuke Koya
Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease. Journal of diabetes investigation 10 (3) (2018)
Emi Kawakita, Keizo Kanasaki, Taro Hirai, Shin-Ichi Tsuda, Ai Watanabe, Kyoko Nitta, Munehiro Kitada, Yoshio Ogura, Yuta Takagaki, Mizue Fujii, Takako Nagai, Keiji Shimada, Susumu Takagi, Yuiko Mizunuma, Itaru Monno, Fujimoto Shino, Hiroshi Minato, Nobuhiko Miyatake, Atsushi Nakagawa, Daisuke Koya
Severe electrolytes disorders with the interstitial kidney alterations in the patient with the history of total thyroidectomy and parathyroidectomy: possible role of vitamin D deficiency. Clinical case reports 6 (6) (2018)
Yoshio Ogura, Munehiro Kitada, Itaru Monno, Keizo Kanasaki, Ai Watanabe, Daisuke Koya
Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats. Redox report : communications in free radical research 23 (1) (2018)
Swayam Prakash Srivastava, Jinpeng Li, Munehiro Kitada, Hiroki Fujita, Yuichiro Yamada, Julie E Goodwin, Keizo Kanasaki, Daisuke Koya
SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis. Cell death & disease 9 (10) (2018)
Susumu Takagi, Jinpeng Li, Yuta Takagaki, Munehiro Kitada, Kyoko Nitta, Toshiyuki Takasu, Keizo Kanasaki, Daisuke Koya
Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet. Journal of diabetes investigation 9 (5) (2018)
Megumi Kanasaki, Swayam Prakash Srivastava, Fan Yang, Ling Xu, Sumiyo Kudoh, Munehiro Kitada, Norikazu Ueki, Hyoh Kim, Jinpeng Li, Satoru Takeda, Keizo Kanasaki, Daisuke Koya
Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice. Scientific reports 7 (1) (2017)